| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.092 | 0.03 |